BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/25/2020 2:44:04 PM | Browse: 896 | Download: 1966
 |
Received |
|
2020-06-03 05:08 |
|
Peer-Review Started |
|
2020-06-03 05:09 |
|
First Decision by Editorial Office Director |
|
2020-09-13 14:31 |
|
Return for Revision |
|
2020-09-13 14:31 |
|
Revised |
|
2020-09-22 07:53 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-10-10 10:24 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-10-13 04:54 |
|
Articles in Press |
|
2020-10-13 04:54 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-11-20 01:13 |
|
Publish the Manuscript Online |
|
2020-11-25 14:44 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Azacitidine decreases reactive oxygen species production in peripheral white blood cells: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hidekazu Hasunuma, Naomi Shimizu, Hiromitsu Yokota and Ichiro Tatsuno |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Naomi Shimizu, MD, PhD, Assistant Professor, Department of Hematology, Toho University Medical Center Sakura Hospital, No. 564-1, Shimoshizu, Sakura 2858741, Japan. naomis-cib@umin.ac.jp |
| Key Words |
Myelodysplastic syndrome; Reactive oxygen species; Diacron-reactive oxygen metabolites; Ferritin; Azacitidine; Case report |
| Core Tip |
Accumulation of reactive oxygen species (ROS) contributes to the development and progression of cancer. We reported a case of myelodysplastic syndrome that showed decreased ROS production by white blood cells, decreased diacron-reactive oxygen metabolites (d-ROMs) in serum and decreased Wilms’ tumor 1 after azacitidine therapy, which can improve hematopoiesis by decreasing ROS and d-ROMs production. |
| Publish Date |
2020-11-25 14:44 |
| Citation |
Hasunuma H, Shimizu N, Yokota H, Tatsuno I. Azacitidine decreases reactive oxygen species production in peripheral white blood cells: A case report. World J Clin Cases 2020; 8(22): 5657-5662 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i22/5657.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i22.5657 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
